Neurizon Therapeutics LimitedASX: NUZ

Neurizon secures $6million R&D Tax Incentive Rebate

· Issued by Neurizon Therapeutics Limited

Filed with ASX · · 2 pages · English

• Neurizon® has secured a cash rebate of $6.0 million from the Australian Government’s Research and Development (R&D) Tax Incentive program for the 2025 financial year (FY2025), reflecting a 48.5% cash rebate on eligible R&D activities undertaken in both Australia and overseas. • This significant rebate, a non-dilutive cornerstone of Neurizon’s funding strategy, demonstrates the benefit of the Com

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases